chr19-17726415-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000324096.9(MAP1S):c.1031C>T(p.Ala344Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,573,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000324096.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP1S | NM_018174.6 | c.1031C>T | p.Ala344Val | missense_variant | 5/7 | ENST00000324096.9 | NP_060644.4 | |
MAP1S | NM_001308363.2 | c.953C>T | p.Ala318Val | missense_variant | 5/7 | NP_001295292.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP1S | ENST00000324096.9 | c.1031C>T | p.Ala344Val | missense_variant | 5/7 | 1 | NM_018174.6 | ENSP00000325313.3 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000347 AC: 6AN: 173060Hom.: 0 AF XY: 0.0000313 AC XY: 3AN XY: 95812
GnomAD4 exome AF: 0.00000845 AC: 12AN: 1420678Hom.: 0 Cov.: 40 AF XY: 0.00000568 AC XY: 4AN XY: 704700
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.1031C>T (p.A344V) alteration is located in exon 5 (coding exon 5) of the MAP1S gene. This alteration results from a C to T substitution at nucleotide position 1031, causing the alanine (A) at amino acid position 344 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at